Differences in steroid 5α-reductase iso-enzymes expression between normal and pathological human prostate tissue

Journal of Steroid Biochemistry and Molecular Biology

Volumn 68, Issue 5-6, 1999, Pages 189-195

  Iehlé, Catherine ^a   Radvanyi, François ^b   Gil Diez De Medina, Sixtina ^b   Ouafik, L'Houcine ^a   Gérard, Henriette ^a   Chopin, Dominique ^c   Raynaud, Jean Pierre ^d   Martin, Pierre Marie ^a  

^a INSERM   (France)

^b INSTITUT CURIE   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

5 reductase; Epithelium; ISH; Prostate; RT PCR; Stroma

Indexed keywords

ISOENZYME; MESSENGER RNA; STEROID 5ALPHA REDUCTASE;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; COMPARATIVE STUDY; ENZYMOLOGY; EPITHELIUM; GENETICS; METABOLISM; PROSTATE; PROSTATE TUMOR;

EPITHELIUM; HUMANS; IN SITU HYBRIDIZATION; ISOENZYMES; MALE; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 0032588595     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(99)00030-8     Document Type: Article

References (26)

1. Andersson S., Russell D.W. Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases. Proc. Natl. Acad. Sci. USA. 87:1990;3640-3644.
2. Andersson S., Berman D.M., Jenkins E.P., Russell D.W. Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism. Nature. 354:1991;159-161.
3. Jenkins E.P., Andersson S., Imperato-McGinley J., Wilson J.D., Russell D.W. Genetic and pharmacological evidence for more than one human steroid 5α-reductase. J. Clin. Invest. 89:1992;293-300.
4. Thigpen A.E., Davis D.L., Milatovich A., Mendonca B., Imperato-McGinley J., Griffin J.E., Francke U., Wilson J.D., Russell D.W. Molecular genetics of steroid 5α-reductase 2 deficiency. J. Clin. Invest. 90:1992;799-809.
5. Labrie F., Sugimoto Y., Luu-The V., Simard J., Lachance Y., Bachvarov D., Leblanc G., Durocher F., Paquet N. Structure of human type Il 5(α-reductase gene. Endocrinology. 131:1992;1571-1573.
6. Iehlé C., Délos S., Filhol O., Martin P.M. Baculovirus-directed expression of human prostatic steroid 5α-reductase 1 in an active form. J. Steroid Biochem. Mol. Biol. 46:1993;177-182.
7. Iehlé C., Délos S., Guirou O., Tate R., Raynaud J-P., Martin P.M. Human prostatic steroid 5α-reductase isoforms - a comparative study of selective inhibitors. J. Steroid Biochem. Mol. Biol. 54:1995;273-279.
8. Jenkins E.P., Hsieh C.L., Mllatovich A., Normington K., Berman D.M., Francke U., Russell D.W. Characterization and chromosomal mapping of a human steroid 5α-reductase gene and pseudogene and mapping of the mouse homologue. Genomics. 11:1991;1102-1112.
9. Luu-The V., Sugimoto Y., Puy L., Labrie Y., Lopez Solache I., Singh M., Labrie F. Characterization, expression and immunohistochemical localisation of 5α-reductase in human skin. J. Invest. Dermatol. 102:1994;221-226.
10. Rennie P.S., Bruchovsky N., McLoughlin M.G., Batzhold F.H., Dustan-Adams E.E. Kinetic analysis of 5α-reductase isozymes in benign prostatic hyperplasia. J. Steroid Biochem. 19:1983;169-173.
11. Hudson R.W. Comparison of nuclear 5α-reductase activities in the stromal and epithelial fractions of human prostatic tissue. J. Steroid Biochem. 26:1987;349-353.
12. Le Goff J.M., Martin P.M., Ojasoo T., Raynaud J-P. Non-michaelian behaviour of 5α-reductase in human prostate. J. Steroid Biochem. 33:1989;155-163.
13. Hirsch K.S., Jones C.D., Audia J.E., Andersson S., McQuaid L., Stamm N.B., Neubauer B.L., Pennington P., Toomey R.E., Russell D.W. LY191704: a selective, nonsteroidal inhibitor of human steroid 5α-reductase type 1. Proc. Natl. Acad. Sci. USA. 90:1993;5277-5281.
14. Thigpen A.E., Silver R.I., Gulleyardo J.M., Casey M.L., McConnell J.D., Russell D.W. Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression. J. Clinic. Invest. 92:1993;903-910.
15. Bonnet P., Reiter E., Bruyninx M., Sente B., Dombrowicz D., De Leval J., Closset J., Hennen G. Benign prostatic hyperplasia and normal prostate aging: differences in types 1 and Il 5α-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels. J. Clin. Endocrinol. Metab. 77:1993;1203-1208.
16. Bruchovsky N., Sadar M.D., Akakura K., Goldenberg S.L., Matsuoka K., Rennie P.S. Characterisation of 5α-reductase gene expression in stroma and epithelium of human prostate. J. Steroid Biochem. Mol. Biol. 59:1996;397-404.
17. Délos S., Iehlé C., Martin P.M., Raynaud J-P. Inhibition of the activity of 'basic' 5α-reductase (type 1) detected in DU145 cells and produced in insect cells. J. Steroid Biochem. Mol. Biol. 48:1994;347-352.
18. Kaefer M., Audia J.E., Bruchovsky N., Goode R.L., Hsiao K.C., Leibovitch I.Y., Krushinski J.H., Lee C., Steidle C.P., Sutkowski D.M., Neubauer B.L. Characterisation of type 1 5α-reductase activity in DU 145 human prostate adenocarcinoma cells. J. Steroid Biochem. Mol. Biol. 58:1996;195-205.
19. Ouafik L'.H, May V., Saffen D.W., Eipper B.A. Thyroid hormone regulation of peptidylglycine α-amidating monooxygenase expression in anterior pituitary gland. Mol. Endocrinol. 10:1990;1497-1505.
20. Chirgwin J.M., Przybyla A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
21. Peterson M.G., Tanese N., Pugh B.F., Tjian R. Functional domains and upstream activation properties of cloned human TATA binding protein. Science. 248:1990;1625-1630.
22. Gil de Diez Medina S., Chopin D., El Marjou A., Delouvée A., Larochelle W.J., Hoznek A., Abbou C., Aaronson S.A., Thiery J.P., Radvanyi F. Decreased expression of keratinocyte growth factor receptor in a subset of human transitional cell bladder carcinomes. Oncogene. 14:1997;323-330.
23. Stone K.R., Mickey D.D., Wunderli H., Mickey G., Paulson D.F. Isolation of human prostate carcinoma cell line (DU145). Int. J. Cancer. 21:1978;274-281.
24. Smith C.M., Ballard S.A., Worman N., Buettner R., Masters J.R.W. 5α-Reductase expression by prostate cancer cell lines and benign prostatic hyperplasia in vitro. J. Clin. Endocrino. Metab. 81:1996;1361-1366.
25. Eicheler W., Tuohimaa P., Vilja P., Adermann K., Forssmann W.G., Aumüller G. Immunocytochemical localisation of human 5α-reductase 2 with polyclonal antibodies in androgen target and non-target human tissues. J. Histochem. Cytochem. 42:1994;667-675.
26. Cuhna G.R., Donjacour A.A., Cooke P.S., Mee S., Bigsby R.M., Higgins S.J., Sugimura Y. The endocrinology and developmental biology of the prostate. Endocrinol. Rev. 8:1987;338-360.